Correlation of a multi-cytokine panel with clinical disease activity in patients with rheumatoid arthritis

Clinical Biochemistry
Nataliya MilmanRonald A Booth

Abstract

Explore the potential use of a cytokine panel as biochemical markers of disease activity in rheumatoid arthritis (RA) patients. 57 adult RA patients were assessed using five validated clinical disease activity tools: Health Assessment Questionnaire (HAQ), standard 28-joint Disease Activity Score (DAS28), DAS28 using C-reactive protein (DAS28-CRP), Clinical Disease Activity Index (CDAI), and Simple Disease Activity Index (SDAI). Plasma cytokine levels (IL-2, IL-4, IL-6, IL-8, IL-10, VEGF, IFN-γ, TNF-α, IL1α, IL1β, MCP1, and EGF) were measured in 47 of the 57 patients and correlated with clinical indicators. We found significant correlations between plasma levels of IL-6 and all clinical measures of disease activity; Spearman coefficients (p values) were: HAQ: 0.347(0.017); DAS28: 0.409(0.005); DAS-CRP: 0.378(0.011); CDAI: 0.312(0.033); SDAI: 0.310(0.039); ESR: 0.448(0.002); and CRP: 0.513(0.001). IFN-γ also correlated with DAS-CRP: 0.309(0.039) and SDAI: 0.301(0.044). Furthermore, the levels of IL-6 and IFN-γ increased significantly with worsening disease, as defined by the European League Against Rheumatism (EULAR) classification of disease activity. A significant correlation between plasma levels of IL-6 and clinical disease a...Continue Reading

References

Feb 1, 1980·Arthritis and Rheumatism·J F FriesH R Holman
Jan 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·J K LackiW Müller
Jul 5, 2006·Arthritis Research & Therapy·Thierry LequerréJean-Philippe Salier
Sep 14, 2007·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Lene S KnudsenJulia S Johansen
Oct 30, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Peter A KavsakAllan S Jaffe

❮ Previous
Next ❯

Citations

Aug 10, 2012·Medizinische Klinik, Intensivmedizin und Notfallmedizin·J WilhelmK Werdan
Jun 28, 2012·Arthritis Care & Research·Jeffrey R CurtisMichael E Weinblatt
May 14, 2011·Arthritis and Rheumatism·Inge R Klein-WieringaAndreea Ioan-Facsinay
Apr 22, 2015·JACC. Cardiovascular Imaging·Ntobeko A B NtusiTheodoros D Karamitsos
Mar 25, 2014·Allergologia et immunopathologia·A K ShrivastavaH Sharma
Feb 20, 2017·Cytokine·Kensuke KoyamaKenichi Matsuda
Nov 26, 2011·Expert Review of Clinical Pharmacology·Xiaoping Zhang, Richard Peck
Jun 20, 2020·Critical Reviews in Clinical Laboratory Sciences·Elena SavvateevaAlla Rubina
Feb 26, 2016·Molecular and Cellular Biochemistry·Roma PahwaNibhriti Das
Feb 17, 2017·Journal of Translational Medicine·Kely Campos NavegantesMarta Chagas Monteiro
Aug 8, 2019·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Maria Gonzalez-OrozcoVianney Ortiz-Navarrete
Jul 21, 2017·Rheumatology International·Fawaz Y AziziehRaj Raghupathy
Jan 2, 2021·Seminars in Arthritis and Rheumatism·Janet E Pope, Ernest H Choy
Aug 20, 2021·Annals of the Rheumatic Diseases·György NagyJacob M van Laar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.